Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1555)	1/8/1999 11:23:00 PM
From: Steve Johnston	Respond to of 2173

Sounds like somebody may have caught wind of a new major partner. Some big volume traders jumped in today. Regardless, I intend to stay in to see, at about 65 cents average price I've almost doubled my money already. I only wish I was always this shrewd. Regards.

To: Rudy Saucillo who wrote (1555)	1/9/1999 8:20:00 PM
From: arnie h	Read Replies (1) \| Respond to of 2173

Rudy: Is there any signifigance to the **s around amazing? I presume you're amazed by the sharp gain Friday. With $8/share tax loss for the right partner, a decent candidate through Phase 1, some cash and little debt, a bit of science that may be of value for diabetes/ weight control/ and hdl/ldl ratio, and even a small chance of approval at some point for pramlinitide; it does seem possible a buyer may be interested. Who knows? Hopefully, somebody does. Regards, Arnie